Los Angeles Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-16,034
| Closed | -$488K | – | 1424 |
|
2022
Q2 | $488K | Sell |
16,034
-35,497
| -69% | -$1.08M | ﹤0.01% | 972 |
|
2022
Q1 | $1.34M | Sell |
51,531
-6,740
| -12% | -$175K | 0.01% | 658 |
|
2021
Q4 | $1.19M | Sell |
58,271
-39,790
| -41% | -$812K | ﹤0.01% | 667 |
|
2021
Q3 | $1.89M | Sell |
98,061
-4,939
| -5% | -$95K | 0.01% | 542 |
|
2021
Q2 | $2.29M | Buy |
103,000
+51,026
| +98% | +$1.13M | 0.01% | 558 |
|
2021
Q1 | $1.36M | Buy |
51,974
+7,759
| +18% | +$204K | 0.01% | 760 |
|
2020
Q4 | $826K | Sell |
44,215
-2,840
| -6% | -$53.1K | ﹤0.01% | 1017 |
|
2020
Q3 | $799K | Sell |
47,055
-47,141
| -50% | -$800K | ﹤0.01% | 907 |
|
2020
Q2 | $2.19M | Buy |
94,196
+20,077
| +27% | +$468K | 0.01% | 595 |
|
2020
Q1 | $623K | Buy |
+74,119
| New | +$623K | ﹤0.01% | 839 |
|
2019
Q2 | – | Sell |
-87,715
| Closed | -$1.55M | – | 1460 |
|
2019
Q1 | $1.55M | Sell |
87,715
-104,990
| -54% | -$1.85M | 0.01% | 728 |
|
2018
Q4 | $3.35M | Buy |
192,705
+72,036
| +60% | +$1.25M | 0.02% | 436 |
|
2018
Q3 | $1.8M | Buy |
120,669
+36,952
| +44% | +$551K | 0.01% | 695 |
|
2018
Q2 | $1.33M | Hold |
83,717
| – | – | 0.01% | 814 |
|
2018
Q1 | $1.19M | Sell |
83,717
-50,995
| -38% | -$724K | 0.01% | 778 |
|
2017
Q4 | $1.89M | Buy |
134,712
+47,311
| +54% | +$662K | 0.01% | 683 |
|
2017
Q3 | $1.25M | Buy |
87,401
+31,140
| +55% | +$445K | 0.01% | 748 |
|
2017
Q2 | $886K | Sell |
56,261
-6,440
| -10% | -$101K | 0.01% | 788 |
|
2017
Q1 | $865K | Buy |
62,701
+8,831
| +16% | +$122K | 0.01% | 760 |
|
2016
Q4 | $953K | Hold |
53,870
| – | – | 0.01% | 716 |
|
2016
Q3 | $1.04M | Buy |
53,870
+6,810
| +14% | +$131K | 0.01% | 709 |
|
2016
Q2 | $918K | Buy |
+47,060
| New | +$918K | 0.01% | 727 |
|